These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 26854258)

  • 21. Effects of surgical procedures on the occurrence and development of postoperative portal vein thrombosis in patients with cirrhosis complicated by portal hypertension.
    Sun L; Zhou H; Gu L; Jiang C; Liu Y; Xu Q
    Int J Surg; 2015 Apr; 16(Pt A):31-35. PubMed ID: 25701619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension.
    Kinjo N; Kawanaka H; Akahoshi T; Tomikawa M; Yamashita N; Konishi K; Tanoue K; Shirabe K; Hashizume M; Maehara Y
    Br J Surg; 2010 Jun; 97(6):910-6. PubMed ID: 20474001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coagulation imbalance may not contribute to the development of portal vein thrombosis in patients with cirrhosis.
    Chen H; Qi X; He C; Yin Z; Fan D; Han G
    Thromb Res; 2013 Feb; 131(2):173-7. PubMed ID: 23157737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the Model for End-stage Liver Disease scoring system.
    Abdel-Razik A; Mousa N; Elhelaly R; Tawfik A
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):585-92. PubMed ID: 25769098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Portal vein thrombosis is not associated with increased mortality among patients with cirrhosis.
    Berry K; Taylor J; Liou IW; Ioannou GN
    Clin Gastroenterol Hepatol; 2015 Mar; 13(3):585-93. PubMed ID: 25459555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study.
    Qi X; He C; Guo W; Yin Z; Wang J; Wang Z; Niu J; Bai M; Yang Z; Fan D; Han G
    Liver Int; 2016 May; 36(5):667-76. PubMed ID: 26235541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis.
    Pettinari I; Vukotic R; Stefanescu H; Pecorelli A; Morelli M; Grigoras C; Sparchez Z; Andreone P; Piscaglia F;
    Am J Gastroenterol; 2019 Feb; 114(2):258-266. PubMed ID: 30538290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis.
    Senzolo M; M Sartori T; Rossetto V; Burra P; Cillo U; Boccagni P; Gasparini D; Miotto D; Simioni P; Tsochatzis E; A Burroughs K
    Liver Int; 2012 Jul; 32(6):919-27. PubMed ID: 22435854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presence of portal vein thrombosis in liver cirrhosis is strongly associated with low levels of ADAMTS-13: a pilot study.
    Lancellotti S; Basso M; Veca V; Sacco M; Riccardi L; Pompili M; De Cristofaro R
    Intern Emerg Med; 2016 Oct; 11(7):959-67. PubMed ID: 27220954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.
    Han G; Qi X; He C; Yin Z; Wang J; Xia J; Yang Z; Bai M; Meng X; Niu J; Wu K; Fan D
    J Hepatol; 2011 Jan; 54(1):78-88. PubMed ID: 20932597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis.
    Luca A; Caruso S; Milazzo M; Marrone G; Mamone G; Crinò F; Maruzzelli L; Miraglia R; Floridia G; Vizzini G
    Radiology; 2012 Oct; 265(1):124-32. PubMed ID: 22891357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver transplantation in adults with portal vein thrombosis: Data from the China Liver Transplant Registry.
    Gao PJ; Gao J; Li Z; Hu ZP; Leng XS; Zhu JY
    Clin Res Hepatol Gastroenterol; 2016 Jun; 40(3):327-332. PubMed ID: 26500198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiphospholipid antibodies are related to portal vein thrombosis in patients with liver cirrhosis.
    Romero Gómez M; Suárez García E; López Lacomba D; Marchante I; Grande L; Castro Fernandez M
    J Clin Gastroenterol; 2000 Oct; 31(3):237-40. PubMed ID: 11034005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis.
    Tripodi A; Primignani M; Lemma L; Chantarangkul V; Mannucci PM
    J Hepatol; 2013 Aug; 59(2):265-70. PubMed ID: 23583273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis.
    La Mura V; Braham S; Tosetti G; Branchi F; Bitto N; Moia M; Fracanzani AL; Colombo M; Tripodi A; Primignani M
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1146-1152.e4. PubMed ID: 29066371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Coagulation, Fibrinolysis and Endothelial Biomarkers in Cirrhotic Patients With or Without Portal Venous Thrombosis.
    Ren W; Zhang J; Chen Y; Wen M; Su Y; Zhao Y; Lu S; Wu J
    Clin Appl Thromb Hemost; 2020; 26():1076029620982666. PubMed ID: 33356499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study.
    Nery F; Chevret S; Condat B; de Raucourt E; Boudaoud L; Rautou PE; Plessier A; Roulot D; Chaffaut C; Bourcier V; Trinchet JC; Valla DC;
    Hepatology; 2015 Feb; 61(2):660-7. PubMed ID: 25284616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis.
    Rodriguez-Castro KI; Vitale A; Fadin M; Shalaby S; Zerbinati P; Sartori MT; Landi S; Pettinari I; Piscaglia F; Han G; Burra P; Simioni P; Senzolo M
    Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):34-42. PubMed ID: 30188408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation.
    D'Avola D; Bilbao JI; Zozaya G; Pardo F; Rotellar F; Iñarrairaegui M; Quiroga J; Sangro B; Herrero JI
    Transplant Proc; 2012 Nov; 44(9):2603-5. PubMed ID: 23146469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnosis and treatment of portal thrombosis in liver cirrhosis].
    Seijo S; García-Criado A; Darnell A; García-Pagán JC
    Gastroenterol Hepatol; 2012 Nov; 35(9):660-6. PubMed ID: 22534116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.